Hackam DG - Search Results

1

Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.

Hackam DG, Tan MK, Lin PJ, Mehta PG, Jaffer S, Kates M, Oh M, Grima EA, Langer A, Goodman SG; Vascular Protection Registry; Guideline Oriented Approach in Lipid Lowering Registry Investigators. Hackam DG, et al. J Vasc Surg. 2006 Oct;44(4):776-81. doi: 10.1016/j.jvs.2006.05.057. Epub 2006 Aug 23. J Vasc Surg. 2006. PMID: 16930931 Free article.

2

Oral anticoagulant therapy in patients with coronary artery disease.

Hackam DG, Anand SS, Yusuf S. Hackam DG, et al. Semin Vasc Med. 2003 Aug;3(3):323-32. doi: 10.1055/s-2003-44468. Semin Vasc Med. 2003. PMID: 15199466 Review.

3

How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry.

Hackam DG, Tan MK, Honos GN, Leiter LA, Langer A, Goodman SG; Vascular Protection registry investigators. Hackam DG, et al. Am Heart J. 2004 Dec;148(6):1028-33. doi: 10.1016/j.ahj.2004.04.034. Am Heart J. 2004. PMID: 15632889

4

Cardiovascular risk prevention in peripheral artery disease.

Hackam DG. Hackam DG. J Vasc Surg. 2005 Jun;41(6):1070-3. doi: 10.1016/j.jvs.2005.03.009. J Vasc Surg. 2005. PMID: 15944615 Free article. Review.

5

Management of risk in peripheral artery disease: recent therapeutic advances.

Hackam DG, Goodman SG, Anand SS. Hackam DG, et al. Am Heart J. 2005 Jul;150(1):35-40. doi: 10.1016/j.ahj.2005.01.008. Am Heart J. 2005. PMID: 16084148 Review.

6

Perioperative beta-blocker therapy in vascular surgery: clinical update.

Hackam DG. Hackam DG. J Vasc Surg. 2006 Mar;43(3):632-4. doi: 10.1016/j.jvs.2005.12.014. J Vasc Surg. 2006. PMID: 16520187 Free article. Review.

7

Contemporary management of dyslipidemia in high-risk patients: targets still not met.

Yan AT, Yan RT, Tan M, Hackam DG, Leblanc KL, Kertland H, Tsang JL, Jaffer S, Kates ML, Leiter LA, Fitchett DH, Langer A, Goodman SG; Vascular Protection (VP) and Guidelines Oriented Approach to Lipid Lowering (GOALL) Registries Investigators. Yan AT, et al. Among authors: hackam dg. Am J Med. 2006 Aug;119(8):676-83. doi: 10.1016/j.amjmed.2005.11.015. Am J Med. 2006. PMID: 16887414

8

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.

Hackam DG, Thiruchelvam D, Redelmeier DA. Hackam DG, et al. Lancet. 2006 Aug 19;368(9536):659-65. doi: 10.1016/S0140-6736(06)69250-7. Lancet. 2006. PMID: 16920471

9

Antithrombotic treatment for peripheral arterial disease.

Hackam DG, Eikelboom JW. Hackam DG, et al. Heart. 2007 Mar;93(3):303-8. doi: 10.1136/hrt.2006.102350. Epub 2006 Oct 11. Heart. 2007. PMID: 17035509 Free PMC article. Review.

10

Intensive reduction of low-density lipoprotein-cholesterol: implications of recent trials.

Hackam DG. Hackam DG. Am J Cardiovasc Drugs. 2006;6(6):367-71. doi: 10.2165/00129784-200606060-00003. Am J Cardiovasc Drugs. 2006. PMID: 17192126 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters